Health Care Down After Pfizer Warning -- Health Care Roundup
Dow Jones12-17 06:15
Health-care companies fell after one Big Pharma company's outlook lagged Wall Street expectations.
Shares of Pfizer slid after the New York drug giant issued its 2026 guidance, expecting its adjusted earnings per share to come in below this year's figures, and revised its 2025 revenue outlook.
Congressional Republican leaders appeared to close the door on compromise efforts to renew expiring Affordable Care Act subsidies before the start of the new year, rejecting proposals that would head off sharp increases in health-insurance costs.
Write to Rob Curran at rob.curran@dowjones.com
(END) Dow Jones Newswires
December 16, 2025 17:15 ET (22:15 GMT)
Copyright (c) 2025 Dow Jones & Company, Inc.
At the request of the copyright holder, you need to log in to view this content
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments